首页> 外文OA文献 >Development and validation of HPLC and CE methods for simultaneous determination of amlodipine and atorvastatin in the presence of their acidic degradation products in tablets
【2h】

Development and validation of HPLC and CE methods for simultaneous determination of amlodipine and atorvastatin in the presence of their acidic degradation products in tablets

机译:在片剂中存在酸性降解产物的同时测定氨氯地平和阿托伐他汀的HPLC和CE方法的开发和验证

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Two methods were developed for separation and quantitation of amlodipine (AML) and atorvastatin (ATV) in the presence of their acidic degradation products. The first method was a simple isocratic RP-HPLC method while the second was capillary electrophoresis (CE). Degradation products were obtained by acidic hydrolysis of the two drugs and their structures were elucidated for the first time by IR and MS spectra. Degradation products did not interfere with the determination of either drug and the assays were therefore stability-indicating. The linearity of the proposed methods was established over the ranges 1–50 μg mL–1 for AML and ATV in the HPLC method and in the range of 3–50 and 4–50 μg mL-1 for AML and ATV, respectively, in the CE method. The proposed methods were validated according to ICH guidelines. The methods were successfully applied to estimation of AML and ATV in bulk powder and in pharmaceutical dosage forms.
机译:开发了两种方法用于在酸性降解产物存在下对氨氯地平(AML)和阿托伐他汀(ATV)进行分离和定量。第一种方法是简单的等度RP-HPLC方法,第二种方法是毛细管电泳(CE)。通过两种药物的酸性水解获得降解产物,并通过红外光谱和质谱图首次阐明其结构。降解产物不会干扰任何一种药物的测定,因此测定表明稳定性。在HPLC方法中,AML和ATV的拟议方法的线性在1–50μgmL-1范围内,而AML和ATV的线性在3–50和4–50μgmL-1范围内确定。 CE方法。根据ICH指南对提出的方法进行了验证。该方法已成功应用于散装粉末和药物剂型中AML和ATV的估计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号